Demographic and clinical characteristi cs in schizophrenia: A multi center cross-sectional case record study

Turk Psikiyatri Dergisi

Volumn 21, Issue 3, 2010, Pages 1-12

  Yildiz, Mustafa ^a   Yazici, Ayla ^b   Böke, Ömer ^c  

^a KOCAELI UNIVERSITY   (Turkey)

^b Bakirkoy Training and Research Hospital for Psychiatric and Nervous Diseases   (Turkey)

^c ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Age of onset; Demographics; Hospitalization; Physically aggressive behavior; Prognosis; Schizophrenia; Smoking; Suicide attempt; Untreated illness duration

Indexed keywords

EID: 77956809809     PISSN: 13002163     EISSN: None     Source Type: Journal    
DOI: 10.5080/u6178     Document Type: Article

References (58)

1. Aguilar MC, Gurpegui M, Diaz FJ et al. (2005) Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br J Psychiatry, 186:215-21.
2. Alptekin K, Erkoç Ş, Göǧüş AK et al. (2005) Disability in schizophrenia: Clinical correlates and prediction over 1-year follow-up. Psychiatry Research, 135: 103-11.
3. Amerikan Psikiyatri Birliǧi (1994) Mental Bozukluklari{dotless}n Tani{dotless}sal ve Sayi{dotless}msal Elkitabi{dotless}, Dördüncü Baski{dotless} (DSM-IV), (Çev. Ed.: E Köroǧlu) Hekimler Yayi{dotless}n Birliǧi, Ankara, 1995.
4. Belli H, Özçetin A, Ertem Ü et al. (2007) Şizofreni hastalari{dotless}nda bazi{dotless} sosyodemografik özellikler ve tedavi ile ilişkili etkenler. Anadolu Psikiyatri Dergisi, 8(2):102-12.
5. Bobes J, Fillat O, Arango C (2009) Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors. Acta Psychiatr Scand, 119(3):218-25.
6. Bromet EJ, Fennig S (1999) Epidemiology and natural history of schizophrenia. Biological Psychiatry, 46(7): 871-81.
7. Brunette MF, Drake RE (1997) Gender differences in patients with schizophrenia and substance abuse. Compr Psychiatry, 38:109-16.
8. Campo-Arias A, Diaz-Martinez LA, Rueda-Jaimes GE et al. (2006) Smoking is associated with schizophrenia, but not with mood disorders, within a population with low smoking rates: a matched case-control study in Bucaramanga, Colombia. Schizophr Res, 83:269-76.
9. Dalack GW, Healy DJ, Meador-Woodruff JH (1998) Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry, 155(11):1490-501.
10. de Leon J, Diaz FJ (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76:135-57.
11. Eaton WW (19 75) Marital status and schizophrenia. Acta Psychiatr Scand, 52:320-29.
12. Eaton WW, Chen C-Y (2006) Epidemiology. Textbook of schizophrenia. Lieberman JA, Stroup TS, Perkins DO (Ed), Washington DC. The Amerikan Psychiatric Publishing, Inc. s. 17-37.
13. Folnegovic Z, Folnegovic-Smalz V (1994) Schizophrenia in Croatia: age of onset differences between males and females. Schizophr Res, 14:83-91.
14. Fortney JC, Xu S, Dong F (2009) Community-level correlates of hospitalizations for persons with schizophrenia. Psychiatr Serv, 60(6):772-8.
15. Goldstein G, Shemansky WJ (2000) Length and Number of Hospitalizations in Two Cohorts of Veterans With Chronic Schizophrenia. Psychiatr Serv, 51:245-7.
16. Gorwood P, Leboyer M, Jay M et al. (1995) Gender and age at onset in schizophrenia: impact of family history. Am J Psychiatry, 152:208-12.
17. Gupta S, Black DW, Arndt S et al. (1998) Factors Associated With Suicide Attempts Among Patients With Schizophrenia. Psychiatr Serv, 49:1353-5.
18. Häfner H, an der Heiden W, Behrens S et al. (1998) Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull, 24:99-113.
19. Häfner H (2003) Gender differences in schizophrenia. Psychoneuroendocrinology, 28(S:2):17-54.
20. Harrison G, Hopper K, Craig T et al. (2001) Recovery from psychotic illness: a 15-and 25-year international follow-up study. Br J Psychiatry, 178:506-17.
21. Hegarty JD, Baldessarini RJ, Tohen M et al. (1994) One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry, 151:1409-16.
22. an der Heiden W, Häfner H (2000) The epidemiology of onset and course of schizophrenia. Eur Arch Psychiatry Clin Neurosci, 250(6):292-303.
23. Honkonen T, Karlsson H, Koivisto AM (2003) Schizophrenic patients in different treatment settings during the era of deinstitutionalization: three-year follow-up of three discharge cohorts in Finland. Aust N Z J Psychiatry, 37:160-8.
24. Huber G, Gross G, Schüttler R et al. (1980) Longitudinal studies of schizophrenic patients. Schizophr Bull, 6(4): 592-605.
25. Jablensky A, Sartorius N, Ernberg G et al. (1992) Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization Ten-country study. Psychol Med, (Monograph Suppl) 20:43-55.
26. Karşi{dotless}daǧ Ç, Alpay N, Kocabi{dotless}yi{dotless}k A (2005) Şizofreni ve sigara baǧi{dotless}mli{dotless}li{dotless}ǧi{dotless}. Düşünen Adam: Psikiyatri ve Nörolojik Bilimler Dergisi, 18(1):13-20.
27. Kelly C, McCreadie RG (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry, 156:1751-7.
28. Kendler KS, Walsh D (1995) Gender and schizophrenia. Results of an epidemiologically-based family study. Br J Psychiatry, 167:184-92.
29. Kendler KS, Gallagher TJ, Abelson JM et al. (1996) Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry, 53(11):1022-31.
30. Knapp M, Chisholm D, Leese M et al. (2002) Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. Acta Psychiatr Scand, 105(1):42-54.
31. Könnecke R, Häfner H, Maurer K et al. (2000) Main risk factors for schizophrenia: increased familial loading and pre-and perinatal complications antagonize the protective effect of oestrogen in women. Schizophr Res, 44:81-93.
32. Larsen TK, Friis S, Haahr U et al. (2001) Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand, 103(5):323-34.
33. Lay B, Lauber C, Rössler W (2006) Prediction of in-patient use in first-admitted patients with psychosis. Eur Psychiatry, 21(6):401-9.
34. Lay B, Nordt C, Rössler W (2007) Trends in psychiatric hospitalisation of people with schizophrenia: A register-based investigation over the last three decades. Schizophr Res, 97(1-3):68-78.
35. Limosin F, Loze J-Y, Philippe A et al. (2007) Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr Res, 94:23-8.
36. Marzuk PM (1996) Violence, crime, and mental illness. How strong a link. Arch Gen Psychiatry, 53:481-6.
37. Meltzer HY (2002) Suicidality in schizophrenia: a review of the evidence for risk factors and tre atment options. Curr Psychiatry Rep, 4:279-83.
38. Mueser KT, Yarnold PR, Levinson DF et al. (1990) Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull, 16(1):31-56.
39. Murthy GVS, Janakiramaiah N, Gangadhar BN et al. (1998) Sex difference in age at onset of schizophrenia: discrepant findings from India. Acta Psychiatr Scand, 97:321-25.
40. Palmer BA, Shane Pankratz V, Bostwich JM (2005) The lifetime risk of suicide in schizophrenia. A reexamination. Arch Gen Psychiatry, 62(3): 247-53.
41. Patkar A, Gopalakrishan R, Lundy A et al. (2002) Relationship between tobacco smoking and positive and negative symptoms of schizophrenia. J Nerv Ment Dis, 190:604-10.
42. Radomsky ED, Haas GL, Mann JJ et al. (1999) Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am J Psychiatry, 156:(10): 1590-95.
43. Ran MS, Xiang MZ, Li SX et al. (2003) Prevalence and course of schizophrenia in a Chinese rural area, Aust NZJ Psychiatry, 37:452-57.
44. Riecher-Roessler A, Häfner H, Stumbaum M et al. (1994) Can estradiol modulate schizophrenic symptomatology? Schizophrenia Bull, 20:203-14.
45. Roy A (1986) Depression, attempted suicide, and suicide in patients with chronic schizophrenia. Psychiatr Clin North Am, 9:193-206.
46. Rössler W, Salize HJ, van Os J et al. (2005) Size of burden of schizophrenia and psychotic disorders. European Neuropsyhopharmacology,15(4):399-409.
47. Sarandöl A, Akaya C, Cangür Ş et al. (2007) Ayaktan Takip Edilen Şizofreni Hastalari{dotless}nda Cinsiyetin Sosyodemografik Veriler ve Klinik Özelliklerle İlişkisi. Türkiye'de Psikiyatri, 9(2):98-102.
48. Satman I,Yi{dotless}lmaz T, Sengul A et al. (2002) Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 25,1551-6.
49. Saylan M, Üçok A, Uǧuz Ş et al. (2009) Şizofreni hastalari{dotless}nda sosyal si{dotless}ni{dotless}f analizi: 12 haftali{dotless}k tedaviden sonra psikopatolojideki deǧişim. Klinik Psikofarmakoloji Bülteni, 19(1):29-38.
50. Schimmelmann BG, Huber CG, Lambert M et al. (2008) Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res, 42(12): 982-90.
51. Siris SG (2001) Suicide and schizophrenia. J Psychopharmacol, 15(2):127-35.
52. Swanson JW, Swartz MS, Van Dorn RA et al. (2006) A national study of violent behavior in persons with schizophrenia. Arch Gen Psychiatry, 63(5):490-9.
53. Swartz MS, Swanson JW, Hiday VA et al. (1998) Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Soc Psychiatry Psychiatr Epidemiol, 33(Suppl 1):75-80.
54. Tang Y, Gillespie CF, Epstein MP et al. (2007) Gender differences in 542 Chinese inpatients with schizophrenia. Schizophr Res, 97(1-3):88-96.
55. Üçok A, Polat A, Genç A et al. (2004) Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatr Res, 38:163-8.
56. Wallace C, Mullen PE, Burgess P (2004) Criminal Offending in Schizophrenia Over a 25-Year Period Marked by Deinstitutionalization and Increasing Prevalence of Comorbid Substance Use Disorders. Am J Psychiatry, 161:716-27.
57. Wieselgren IM, Lindstrom LH (1996) A prospective 1-5year outcome study in first-admitted and readmitted schizophrenic patients; relationship to heredity, premorbid adjustment, duration of disease and education level at index admission and neuroleptic treatment. Acta Psychiatr Scand, 93(1):9-19.
58. Wyatt RJ, Damiani M, Henter I (1998) First-episode schizophrenia: Early intervention and medication discontinuation in the context of course and treatment. Br J Psychiatry, 72 (Suppl 33):77-83.